Qiaomei Cai

Tianjin Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT.

Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT.

Journal: Cancer biology & medicine

Published: March 02, 2026

CDK2 inhibition sensitizes anthracycline-induced immunogenic cell death and enhances the efficacy of anti-PD-1 therapy.

CDK2 inhibition sensitizes anthracycline-induced immunogenic cell death and enhances the efficacy of anti-PD-1 therapy.

Journal: Frontiers in immunology

Published: February 02, 2025

HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses.

HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses.

Journal: Journal of hepatology

Published: November 27, 2024

The aldehyde dehydrogenase ALDH1B1 exerts antiviral effects through the aggregation of the adaptor MAVS.

The aldehyde dehydrogenase ALDH1B1 exerts antiviral effects through the aggregation of the adaptor MAVS.

Journal: Science signaling

Published: January 09, 2024

Interferon-stimulated gene PVRL4 broadly suppresses viral entry by inhibiting viral-cellular membrane fusion.

Interferon-stimulated gene PVRL4 broadly suppresses viral entry by inhibiting viral-cellular membrane fusion.

Journal: Cell & bioscience

Published: August 17, 2023

SERTAD3 induces proteasomal degradation of ZIKV capsid protein and represents a therapeutic target.

SERTAD3 induces proteasomal degradation of ZIKV capsid protein and represents a therapeutic target.

Journal: Journal of medical virology

Published: November 15, 2022

Correction to: Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1.

Correction to: Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1.

Journal: Cellular & molecular immunology

Published: May 13, 2022

CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses.

CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses.

Journal: Cancer immunology research

Published: September 22, 2021

Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagens.

Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagens.

Journal: Cellular & molecular immunology

Published: July 29, 2021

Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1.

Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1.

Journal: Cellular & molecular immunology

Published: July 06, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026